These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha AND Prognosis
99 results:

  • 1. Exploring the role of tRNA-derived small RNAs (tsRNAs) in disease: implications for HIF-1 pathway modulation.
    Wang Q; Ying X; Huang Q; Wang Z; Duan S
    J Mol Med (Berl); 2024 Aug; 102(8):973-985. PubMed ID: 38850298
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Circhif1a induces cetuximab resistance in colorectal cancer by promoting HIF1α-mediated glycometabolism alteration.
    Geng Y; Zheng X; Zhang D; Wei S; Feng J; Wang W; Zhang L; Wu C; Hu W
    Biol Direct; 2024 May; 19(1):36. PubMed ID: 38715141
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Liensinine sensitizes colorectal cancer cells to oxaliplatin by targeting HIF-1α to inhibit autophagy.
    Feng Z; Zhang S; Han Q; Chu T; Wang H; Yu L; Zhang W; Liu J; Liang W; Xue J; Wu X; Zhang C; Wang Y
    Phytomedicine; 2024 Jul; 129():155647. PubMed ID: 38703660
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Isthmin-1 promotes growth and progression of colorectal cancer through the interaction with EGFR and YBX-1.
    Zhou X; Zhang K; Wang C; Teng Y; Yu P; Cai W; Gao W; Li M; Ding Y; Sun P; Chen F; Wang Y; Ma J; Maeshige N; Ma X; Li Q; Liang X; Zhang Y; Su D
    Cancer Lett; 2024 May; 590():216868. PubMed ID: 38593920
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Characterization of cell cycle, inflammation, and oxidative stress signaling role in non-communicable diseases: Insights into genetic variants, microRNAs and pathways.
    D'Antona S; Porro D; Gallivanone F; Bertoli G
    Comput Biol Med; 2024 May; 174():108346. PubMed ID: 38581999
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. microRNA-15a-5p suppresses hypoxia-induced tumor growth and chemoresistance in bladder cancer by binding to eIF5A2.
    Yang J; Xiang H; Cheng M; Jiang X; Chen Y; Zheng L; Yan S; Zhang S; Zhang C; Chen W; Chen D
    Neoplasma; 2024 Feb; 71(1):60-69. PubMed ID: 38506035
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. HIF-1α Mediates Immunosuppression and Chemoresistance in colorectal cancer by Inhibiting CXCL9, -10 and -11.
    Su Y; Liu J; Tian Y; Dong H; Shi M; Zhang J; Li W; Huang Q; Xiang N; Wang C; Liu J; He L; Hu L; Haberman AM; Liu H; Yang X
    Biomed Pharmacother; 2024 Apr; 173():116427. PubMed ID: 38484558
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Expression of an oxysterol-metabolizing enzyme in colorectal cancer and its relation to tumor cell behavior and prognosis.
    Kim KH; Park YL; Park SY; Joo YE
    Pathol Res Pract; 2023 Nov; 251():154875. PubMed ID: 37820439
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinicopathological significance and the associated signaling pathway of p21-activated kinase 1 (PAK1) in colorectal cancer.
    Pyo JS; Min KW; Oh IH; Lim DH; Son BK
    Pathol Res Pract; 2023 Nov; 251():154820. PubMed ID: 37801909
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. CHSY1 promotes CD8
    Sun G; Zhao S; Fan Z; Wang Y; Liu H; Cao H; Sun G; Huang T; Cai H; Pan H; Rong D; Gao Y; Tang W
    J Exp Clin Cancer Res; 2023 Sep; 42(1):248. PubMed ID: 37749638
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Estrogen receptor β affects hypoxia response in colorectal cancer cells.
    Rawłuszko-Wieczorek AA; Lipowicz J; Nowacka M; Ostrowska K; Pietras P; Blatkiewicz M; Ruciński M; Jagodziński PP; Nowicki M
    Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166894. PubMed ID: 37748565
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A reciprocal feedback between colon cancer cells and Schwann cells promotes the proliferation and metastasis of colon cancer.
    Han S; Wang D; Huang Y; Zeng Z; Xu P; Xiong H; Ke Z; Zhang Y; Hu Y; Wang F; Wang J; Zhao Y; Zhuo W; Zhao G
    J Exp Clin Cancer Res; 2022 Dec; 41(1):348. PubMed ID: 36522730
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Identification of fatty acid metabolism-related lncRNAs in the prognosis and immune microenvironment of colon adenocarcinoma.
    Wu S; Gong Y; Chen J; Zhao X; Qing H; Dong Y; Li S; Li J; Wang Z
    Biol Direct; 2022 Jul; 17(1):19. PubMed ID: 35902970
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. circEXOC6B interacting with RRAGB, an mTORC1 activator, inhibits the progression of colorectal cancer by antagonizing the hif1a-RRAGB-mTORC1 positive feedback loop.
    Li X; Wang J; Lin W; Yuan Q; Lu Y; Wang H; Chen Y; Chen L; Dai P; Long H; Li X
    Mol Cancer; 2022 Jun; 21(1):135. PubMed ID: 35739524
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Hypoxia-induced HIF-1α/lncRNA-PMAN inhibits ferroptosis by promoting the cytoplasmic translocation of ELAVL1 in peritoneal dissemination from gastric cancer.
    Lin Z; Song J; Gao Y; Huang S; Dou R; Zhong P; Huang G; Han L; Zheng J; Zhang X; Wang S; Xiong B
    Redox Biol; 2022 Jun; 52():102312. PubMed ID: 35447413
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. OLA1 promotes colorectal cancer tumorigenesis by activation of HIF1α/CA9 axis.
    Liu Y; Kong XX; He JJ; Xu YB; Zhang JK; Zou LY; Ding KF; Xu D
    BMC Cancer; 2022 Apr; 22(1):424. PubMed ID: 35440019
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. CD133(+)HIF-1α(-) Expression After Chemoradiotherapy Predicts Poor prognosis in Rectal cancer.
    Tachikawa Y; Kawai K; Ozaki K; Nozawa H; Sasaki K; Murono K; Emoto S; Kishikawa J; Yokoyama Y; Abe S; Nagai Y; Anzai H; Sonoda H; Ishihara S
    Anticancer Res; 2022 Apr; 42(4):2033-2043. PubMed ID: 35347026
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Zinc finger protein 384 enhances colorectal cancer metastasis by upregulating MMP2.
    Yan Z; Zhou Y; Yang Y; Zeng C; Li P; Tian H; Tang X; Zhang G
    Oncol Rep; 2022 Mar; 47(3):. PubMed ID: 35029289
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Induction of lncRNA NORAD accounts for hypoxia-induced chemoresistance and vasculogenic mimicry in colorectal cancer by sponging the miR-495-3p/ hypoxia-inducible factor-1α (HIF-1α).
    Zhang L; Wu H; Zhang Y; Xiao X; Chu F; Zhang L
    Bioengineered; 2022 Jan; 13(1):950-962. PubMed ID: 34969360
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Hypoxia Drives Centrosome Amplification in cancer Cells via HIF1α-dependent Induction of Polo-Like Kinase 4.
    Mittal K; Kaur J; Sharma S; Sharma N; Wei G; Choudhary I; Imhansi-Jacob P; Maganti N; Pawar S; Rida P; Toss MS; Aleskandarany M; Janssen EA; Søiland H; Gupta MV; Reid MD; Rakha EA; Aneja R
    Mol Cancer Res; 2022 Apr; 20(4):596-606. PubMed ID: 34933912
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.